ARTICLE | Clinical News
RiVax: Completed Phase Ib enrollment
November 8, 2010 8:00 AM UTC
Soligenix completed enrollment of about 20 healthy volunteers in an open-label, U.S. Phase Ib trial to evaluate 3 undisclosed intramuscular doses of RiVax administered with an aluminum adjuvant given ...